Clinical Study
Korea Pilot Study
Completed Clinical Trial (First-in-man study)
DENEX has demonstrated superb efficacy and safety in pilot study.
DETAILS | |
---|---|
Enrollment | 16 participants. |
Allocation | N/A (Single-Arm). |
Masking | None (Open Label). |
# of trial centers | 4 (multi). |
Inclusion criteria | Office SBP > 150 mmHg. Daytime AMSBP > 140 mmHg. > 3 anti-HTN meds incl. diuretics. |
RESULTS | |
---|---|
Safety issue | None |
Procedure time | 20.3 + 10.9 minutes (Min. 12 minutes, Max. 45 minutes). |